Logo

Accelr8, BD Move Closer to Rapid Bacterial Dx Development Agreement

Apr 01, 2008
NEW YORK (GenomeWeb News) – Accelr8 Technology said today that it has reached an agreement in principle with Becton Dickinson to fund an 18-month milestone project for Accelr8’s rapid bacterial diagnostic system.
 
Under terms of the preliminary pact, BD will receive an option to license the resulting technology to develop and sell a clinical diagnostic system for infectious diseases.
 
Last December, BD agreed to pay $100,000 for the right to negotiate the development agreement through yesterday. Accelr8 said at the time that the deal could include licensing rights, an equity investment, a joint development, or other type of development program.  
 
Accelr8 said today it expects the new agreement to be solidified by April 30.

Breaking News
The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.